Price T Rowe Associates Inc 9 Meters Biopharma, Inc. Transaction History

Price T Rowe Associates Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.26 - $0.64 $472 - $1,162	1,816 Added 9.17%	21,623 $6,000
Q1 2022 May 16, 2022	BUY	$0.52 - $1.0 $2,852 - $5,486	5,486 Added 38.31%	19,807 $12,000
Q4 2021 Feb 14, 2022	SELL	$0.85 - $1.33 $4,675 - $7,315	-5,500 Reduced 27.75%	14,321 $14,000
Q3 2021 Nov 15, 2021	BUY	$1.03 - $1.41 $1,545 - $2,115	1,500 Added 8.19%	19,821 $26,000
Q2 2021 Aug 16, 2021	BUY	$1.04 - $1.5 $19,053 - $27,481	18,321 New	18,321 $20,000

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.